Buscar
Mostrando ítems 1-10 de 21
Synthetic homoserine lactone-derived sulfonylureas as inhibitors of vibrio fischeri quorum sensing regulator
(PERGAMON-ELSEVIER SCIENCE LTD, 2008)
Synthetic homoserine lactone-derived sulfonylureas as inhibitors of Vibrio fischeri quorum sensing regulator
(PERGAMON-ELSEVIER, 2008-04-01)
A series of 9 homoserine lactone-derived sulfonylureas substituted by an alkyl chain, some of them bearing a phenyl group at the extremity, have been prepared. All compounds were found to inhibit the action of 3-oxo-hexa ...
Modeling the sorption kinetic of metsulfuron-methyl on Andisols and Ultisols volcanic ash-derived soils: Kinetics parameters and solute transport mechanisms
(2010)
Metsulfuron-methyl sorption kinetic was studied in Andisol and Ultisol soils in view of their distinctive physical and chemical properties: acidic pH and variable surface charge. Different kinetic models were applied to ...
Synthetic homoserine lactone-derived sulfonylureas as inhibitors of vibrio fischeri quorum sensing regulatorBIOORGANIC & MEDICINAL CHEMISTRY
(PERGAMON-ELSEVIER SCIENCE LTD, 2016)
Metabolic effects of antidiabetic drugs on adipocytes and adipokine expression
(Wiley-Liss Inc., 2019)
Neonatal diabetes due to potassium channel mutation: Response to sulfonylurea according to the genotype
(Wiley, 2020)
Objective A precision medicine approach is used to improve treatment of patients with monogenic diabetes. Herein, we searched SU efficiency according to the genotype-phenotype correlation, dosage used, and side effects. ...
Registry of people with diabetes in three Latin American countries: A suitable approach to evaluate the quality of health care provided to people with type 2 diabetes
(Wiley, 2013)
Aims: To implement a patient registry and collect data related to the care provided to people with type 2 diabetes in six specialized centers of three Latin American countries, measure the quality of such care using a ...
The Involvement of Peripheral and Brain Insulin Resistance in Late Onset Alzheimer’s Dementia
(Frontiers Media S.A., 2019)